Keyphrases
Cancer-specific
100%
Genetic Engineering
100%
Non-genetic
100%
Bispecific Antibody
100%
Armed T Cells
100%
Engineering Platform
100%
T Cells
40%
Anticancer
20%
Peripheral Blood Mononuclear Cells
20%
Anti-CD3
20%
Cancer-specific T Cells
20%
Clinical Treatment
10%
Nave
10%
Cancer Cells
10%
Cancer Targeting
10%
Anticancer Activity
10%
Tumor Site
10%
Targeting Ability
10%
Cell Surface
10%
Cell Culture
10%
Gene Transfection
10%
Cellular Technology
10%
SCID Mice
10%
Commercial Production
10%
Human Tumors
10%
Retrovirus
10%
Granzyme
10%
Perforin
10%
Genetic Engineering Technology
10%
Safer Method
10%
Effector T Cells
10%
Cytotoxin
10%
Adoptive Cell Therapy
10%
Tissue Toxicity
10%
T Cell Immunotherapy
10%
CD3 Bispecific
10%
Cytokine Release Syndrome
10%
Medicine and Dentistry
Malignant Neoplasm
100%
T Cell
100%
Genetic Engineering
100%
Bispecific Antibody
58%
Neoplasm
11%
Peripheral Blood Mononuclear Cell
11%
CD3 Antigen
11%
Cytokine
5%
Immunotherapy
5%
In Vitro
5%
Cell Culture
5%
Cell Surface
5%
Cancer Cell
5%
Tumor Necrosis Factor
5%
Genetic Transfection
5%
SCID Mouse
5%
Cell Therapy
5%
Toxicity
5%
Perforin
5%
Cytotoxin
5%
Retroviridae
5%
Granzyme
5%
Cytokine Release Syndrome
5%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
T Cell
100%
Peripheral Blood Mononuclear Cell
11%
Cancer Cell
5%
Cytokine
5%
Transfection
5%
Cell Culture
5%
Tumor Necrosis Factor
5%
SCID Mouse
5%
Retrovirus
5%
Perforin
5%
Granzyme
5%
Cytokine Release Syndrome
5%
Immunology and Microbiology
T Cell
100%
Bispecific Antibody
58%
CD3 Antigen
11%
Peripheral Blood Mononuclear Cell
11%
Immunotherapy
5%
Cancer Cell
5%
Tumor Necrosis Factor
5%
Cell Culture
5%
Cytokine
5%
Cell Surface
5%
SCID Mouse
5%
Genetic Transfection
5%
Retrovirus
5%
Perforin
5%
Granzyme
5%
Cytokine Release Syndrome
5%